Caribou Biosciences, Inc.
NASDAQ:CRBU
2.68 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -102.07 | -99.421 | -66.923 | -34.308 | -23.431 |
Depreciation & Amortization
| 3.525 | 1.622 | 0.984 | 0.9 | 0.751 |
Deferred Income Tax
| 0.177 | -0.095 | -1.522 | 0.803 | 0 |
Stock Based Compensation
| 13.75 | 11.716 | 3.449 | 1.002 | 1.234 |
Change In Working Capital
| -7.318 | -4.204 | 29.067 | 0.177 | -8.267 |
Accounts Receivables
| 0.805 | 0.951 | -1.003 | -0.146 | 0.617 |
Inventory
| 0 | 0 | -2.2 | 1.355 | -2.224 |
Accounts Payables
| 1.819 | -2.721 | 1.139 | 0.043 | 1.176 |
Other Working Capital
| -9.942 | -2.434 | 31.131 | -1.075 | -7.836 |
Other Non Cash Items
| -1.355 | -0.584 | 2.426 | -1.789 | -2.293 |
Operating Cash Flow
| -93.291 | -90.966 | -32.519 | -33.215 | -32.006 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -11.613 | -7.054 | -3.121 | -1.315 | -0.884 |
Acquisitions Net
| -4.425 | 0.6 | 0 | 0.01 | 0 |
Purchases Of Investments
| -394.758 | -339.063 | -173.276 | -0.01 | 0 |
Sales Maturities Of Investments
| 338.188 | 252.868 | 0 | 7.668 | 28.117 |
Other Investing Activites
| 4.425 | -0.6 | -1 | 0.01 | 28.117 |
Investing Cash Flow
| -68.183 | -93.249 | -176.397 | 6.363 | 27.233 |
Financing Activities: | |||||
Debt Repayment
| 0 | 0 | -0.119 | -0.113 | -0.045 |
Common Stock Issued
| 154.298 | 2.133 | 321.02 | 0.27 | 0.217 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 137.008 | 2.133 | 112.528 | 1.578 | 0.172 |
Financing Cash Flow
| 154.298 | 2.133 | 433.429 | 1.735 | 0.172 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -7.176 | -182.082 | 224.513 | -25.117 | -4.601 |
Cash At End Of Period
| 51.162 | 58.384 | 240.466 | 15.953 | 41.07 |